Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum92598Research ArticleVnebol'nichnaya pnevmoniya: vzglyad terapevtaDvoretskiyL. I-15032008103344028122021Copyright © 2008, Consilium Medicum2008[Верткин А.Л., Наумов А.В. Скорая медицинская помощь в ведении пациентов с внебольничной пневмонией. Леч. врач. 2005; 8.][Lim M.J., van der Eerden M.M., Laing R et al. Defining community acquired pneumonia severity on presentation to hospital; an international derivation and validition study. Thorax 2003; 58: 377–82.][Meehan T.P., Fine M.J., Krumholz H.M. et al. Quality of care process and outcomes in elderly patients with pneumonia JAMA 1997; 278: 2080.][Houck P.M., Mac Lehose R.F., Niederman M.S. et al. Empiric antibiotic therapy and mortality among Medicare pneumonia inpatients in 10 Western States: 1993, 1995, and 1997. Chest 2001; 119: 1420–6.][Shefet D, Robenshtok E, Paul M, Leibovici L. Empirical atypical coverage for inpatients with community - acquired pneumonia: systematic review of randomized controlled trials. Arch Intern Med 2005; 165 (17): 1992–2000.][Martinez J.A., Horcajada J.P., Almela M еt al. Addition of macrolide to a beta - lactam - baseв empirical antibiotic regimen is associated with lower inhospitality mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2003; 36: 389-95.][File T.M., Sergeti G, Player R et al. A multicеnter randomised study comparing the efficacy and safety of intravenous and or oral levofloxacin versus ceftriaxon and or cefuroxime axetil in treatment of adults with community - acquired pneumonia. Antimicrob Agent Chemother 1997; 41: 1965.][Norrby S.R., Petermann W, Willcox P.A. et al. A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia. Scand J Infect Dis 1998; 30: 397–404.][Kahn J.B., Wiesinger A, Olson W.H. et al. Levofloxacin vs ceftriaxone sodium and erytromycin in the treatment of patients with community - acquired pneumonia at high risk of mortality Abstracts of 7th International Symposium on New Quinolones. Edinburg, UK, 2001; 45.][Ramires J.A. Switch therapy in adult patients with pneumonia. Clin Pulm Med 1995; 2: 327–33.][Христолюбова В.И., Волков Л.И. Ошибки в диагностике и лечении пневмоний в поликлинических условиях. Тер. арх. 2005; 1: 3.][Cornu C, Yzebe D, Leophont P et al. Efficacy of pneumococcal polisacharide vaccine in immunocompetent adults: a meta - analisys of randomized trials. Vaccine 2001; 19: 4780–90.][Дворецкий Л.И., Яковлев С.В. Ошибки в антибактериальной терапии инфекций дыхательных путей в амбулаторной практике. Леч. врач. 2003; 8.][Юдина Л.В. Тактика ведения больных внебольничной пневмонией. Учимся на чужих ошибках. Здоровье Украины. 2007; 2: 19.][Cabana M.D., Rand C.S., Power N.R. et al. Why don\'t physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458-65.][Синопальников А.И. Барьеры на пути внедрения клинических рекомендаций по лечению внебольничной пневмонии: незнание, упрямство или беспечность? Здоровье Украины. 2007; 7: 49.][Рачина С.А., Козлов С.Н., Иделевич Е.Я. и др. Представления врачей поликлиник об этиологии и тактике лечения внебольничной пневмонии в амбулаторных условиях. Пульмонология. 2004; 2: 6–12.]